Anaplastic Thyroid Cancer Arising from Dyshormonogenetic Goiter: c.3070T>C and Novel c.7070T>C Mutation in the Thyroglobulin Gene

Thyroid ◽

10.1089/thy.2020.0248 ◽

2020 ◽

Vol 30 (11) ◽

pp. 1676-1680 ◽

Author(s):

Jee Hee Yoon ◽

A Ram Hong ◽

Hee Kyung Kim ◽

Ho-Cheol Kang

Keyword(s):

Thyroid Cancer ◽

Anaplastic Thyroid Cancer ◽

Thyroglobulin Gene

Download Full-text

Anaplastic thyroid cancer arising froma patient with congenital thyroid dyshormonogenesis; A case report with a novel thyroglobulin gene mutation

Endocrine Abstracts ◽

10.1530/endoabs.70.aep892 ◽

2020 ◽

Author(s):

Jeehee Yoon ◽

Hong A Ram ◽

HeeKyung Kim ◽

Ho-Cheol Kang

Keyword(s):

Thyroid Cancer ◽

Case Report ◽

Gene Mutation ◽

Anaplastic Thyroid Cancer ◽

Thyroid Dyshormonogenesis ◽

Thyroglobulin Gene

Download Full-text

In a Novel Malignant Pleural Effusion Derived Anaplastic Thyroid Cancer Line PD-L1 Expression is Strongly Increased by HDAC Inhibitor Treatment

10.1055/s-0039-1678390 ◽

2019 ◽

Author(s):

Luca Hegedűs ◽

Dominika Rittler ◽

Tamás Garay ◽

Paul Stockhammer ◽

Ildikó Kovács ◽

...

Keyword(s):

Thyroid Cancer ◽

Pleural Effusion ◽

Hdac Inhibitor ◽

Malignant Pleural Effusion ◽

Anaplastic Thyroid Cancer ◽

Cancer Line ◽

Inhibitor Treatment

Download Full-text

The two tyrosine kinase inhibitors, CLM29 and CLM3, have antineoplastic activity in primary cultures from anaplastic thyroid cancer obtained from fine needle aspiration

Endocrine Abstracts ◽

10.1530/endoabs.37.ep867 ◽

2015 ◽

Author(s):

Silvia Martina Ferrari ◽

Poupak Fallahi ◽

Concettina La Motta ◽

Gabriele Materazzi ◽

Francesca Ragusa ◽

...

Keyword(s):

Thyroid Cancer ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitors ◽

Fine Needle Aspiration ◽

Kinase Inhibitors ◽

Primary Cultures ◽

Anaplastic Thyroid Cancer ◽

Needle Aspiration ◽

Antineoplastic Activity ◽

Download Full-text

Neural stem cells expressing cytosine deaminase and interferon-[beta] suppressed the growth and metastasis of anaplastic thyroid cancer cells

Endocrine Abstracts ◽

10.1530/endoabs.56.gp236 ◽

2018 ◽

Author(s):

Hye-Ji Shin ◽

Kyung-Chul Choi

Keyword(s):

Thyroid Cancer ◽

Neural Stem Cells ◽

Cancer Cells ◽

Interferon Beta ◽

Cytosine Deaminase ◽

Anaplastic Thyroid Cancer ◽

Thyroid Cancer Cells

Download Full-text

Anaplastic thyroid cancer: a diagnostic and therapeutic challenge

Endocrine Abstracts ◽

10.1530/endoabs.56.p1199 ◽

2018 ◽

Author(s):

Alexandra Mirica ◽

Rodica Petris ◽

Radu Mirica ◽

Sorin Paun ◽

Corin Badiu ◽

...

Keyword(s):

Thyroid Cancer ◽

Anaplastic Thyroid Cancer ◽

Therapeutic Challenge

Download Full-text

Orphan designation: 2-Methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]-phenol, Treatment of anaplastic thyroid cancer

Case Medical Research ◽

10.31525/cmr-1336911 ◽

2019 ◽

Author(s):

Keyword(s):

Thyroid Cancer ◽

Anaplastic Thyroid Cancer ◽

Orphan Designation ◽

Phenol Treatment

Download Full-text

FDA approves new uses for two drugs administered together for the treatment of BRAF-positive anaplastic thyroid cancer

Case Medical Research ◽

10.31525/fda2-ucm606686.htm ◽

2018 ◽

Author(s):

Keyword(s):

Thyroid Cancer ◽

Anaplastic Thyroid Cancer

Download Full-text

Faculty Opinions recommendation of A multiinstitutional phase 2 trial of pazopanib monotherapy in advanced anaplastic thyroid cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717953610.793459214 ◽

2012 ◽

Author(s):

John H Lazarus

Keyword(s):

Thyroid Cancer ◽

Anaplastic Thyroid Cancer ◽

Phase 2 ◽

Download Full-text

Faculty Opinions recommendation of Efatutazone, an oral PPAR-γ agonist, in combination with paclitaxel in anaplastic thyroid cancer: results of a multicenter phase 1 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718006667.793477593 ◽

2013 ◽

Author(s):

Luca Persani

Keyword(s):

Thyroid Cancer ◽

Phase 1 ◽

Anaplastic Thyroid Cancer ◽

Phase 1 Trial ◽

Ppar Γ ◽

Multicenter Phase

Download Full-text

Faculty Opinions recommendation of Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725308809.793541380 ◽

2018 ◽

Author(s):

Maria Cabanillas

Keyword(s):

Thyroid Cancer ◽

Exome Sequencing ◽

Whole Exome Sequencing ◽

Anaplastic Thyroid Cancer ◽

Mutational Landscape ◽

Download Full-text